Held under the theme "A Festival of Life Science", Drug Discovery 2025 is a celebration that aims to unite scientists from industry and academia working toward the same goal: improving human ...

Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil ...

Expansion of Predictive's AI-driven drug discovery platform to include biomarker discovery and drug repurposing, positioning the company to capitalize on a rapidly growing market projected at $14. ...

Izzie Clarke: 12:14 What an exciting time. Thank you to Dr You Young Song from Standigm, using Merck’s revolutionary retrosynthesis software from the Sigma-Aldrich® portfolio, SYNTHIA.

Significant capital is being invested in artificial intelligence for drug discovery, yet traditional drug development is notoriously slow, inefficient and risky. Enter BioPhy. The Philly-based startup ...

For him, the real promise of A.I. is in refining the entire drug discovery pipeline, including clinical trial optimization. Mergers and acquisitions also present a tantalizing opportunity.